Penserra Capital Management’s SAB Biotherapeutics SABS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-641	Closed	-$9K	–	1177
2022 Q2	$9K	Buy	641 +269	+72%	+$3.78K	﹤0.01%	1285
2022 Q1	$14K	Buy	372 +23	+7%	+$866	﹤0.01%	1352
2021 Q4	$27K	Buy	+349	New	+$27K	﹤0.01%	1184